Cirrhosis Progression | List of Frontiers open access articles

Original Research

Published on 22 Oct 2025

Serum IL-17F as a biomarker of infection-independent cirrhosis progression

in Cytokines and Soluble Mediators in Immunity

Georgios Konstantis
Moritz Passenberg
Clara Guntlisbergen
Andreas Schütte
Björn Jung
Nargiz Nuruzade
Florian Seltsam
Dieter P. Hoyer
Jan Best
Katharina Willuweit

Frontiers in Immunology

doi 10.3389/fimmu.2025.1671288

1,964 views
1 citation

Brief Research Report

Published on 13 Nov 2020

MTHFR rs1801133 Polymorphism Is Associated With Liver Fibrosis Progression in Chronic Hepatitis C: A Retrospective Study

in Translational Medicine

Daniel Pineda-Tenor
Ana Zaida Gómez-Moreno
Juan José Sánchez-Ruano
Tomas Artaza-Varasa
Ana Virseda-Berdices
Amanda Fernández-Rodríguez
Pedro Molina Mendoza
María Ángeles Jiménez-Sousa
Salvador Resino

Frontiers in Medicine

doi 10.3389/fmed.2020.582666

5,805 views
6 citations

Original Research

Published on 01 Mar 2022

UPLC-MS/MS-Based Serum Metabolomics Signature as Biomarkers of Esophagogastric Variceal Bleeding in Patients With Cirrhosis

in Molecular and Cellular Pathology

Yingjie Ai
Xiaoquan Huang
Wei Chen
Ling Wu
Siyu Jiang
Ying Chen
Shiyao Chen

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2022.839781

4,841 views
12 citations

Original Research

Published on 04 Jun 2024

Monomeric C-reactive protein is associated with severity and prognosis of decompensated hepatitis B cirrhosis

in Molecular Innate Immunity

Ning Gao
Ping Yuan
Zhao-Ming Tang
Jia-Geng Lei
Ze-Rui Yang
Mustafa Ahmed
Zhen-Yu Yao
Dan Liang
Yi Wu
Hai-Yun Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1407768

3,245 views
6 citations

Original Research

Published on 07 Jul 2023

Alterations in the gut microbiota and the efficacy of adjuvant probiotic therapy in liver cirrhosis

in Intestinal Microbiome

Zengrong Wu
Hejun Zhou
Deliang Liu
Feihong Deng

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2023.1218552

7,624 views
36 citations

Original Research

Published on 12 Jan 2026

Construction of a Bayesian network-based risk prediction model for hepatocellular carcinoma in cirrhotic patients

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Ni Ma
Jingwei Song
Yuqing Yang

Frontiers in Oncology

doi 10.3389/fonc.2025.1735042

682 views

Articles

Serum IL-17F as a biomarker of infection-independent cirrhosis progression

MTHFR rs1801133 Polymorphism Is Associated With Liver Fibrosis Progression in Chronic Hepatitis C: A Retrospective Study

UPLC-MS/MS-Based Serum Metabolomics Signature as Biomarkers of Esophagogastric Variceal Bleeding in Patients With Cirrhosis

Monomeric C-reactive protein is associated with severity and prognosis of decompensated hepatitis B cirrhosis

Alterations in the gut microbiota and the efficacy of adjuvant probiotic therapy in liver cirrhosis

Construction of a Bayesian network-based risk prediction model for hepatocellular carcinoma in cirrhotic patients